Lai Kenny H W, Wang Xiao Ying, Wan Kelvin H, Barsam Allon, Barnes Scott D, Chiu Alison L S, Cummings Arthur B, Eldanasoury Alaa M, Huang Guofu, Kamiya Kazutaka, Leyssens Barbara, Li Shi-Ming, Packer Mark, Stevens Julian, Yoo Tae Keun, Yeo Lynn, Zhan Xingkai, Lam Dennis S C, Zhou Xingtao
The C-MER Dennis Lam and Partners Eye Center, C-MER International Eye Care Group, Hong Kong, China; Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, China.
Eye Institute and Department of Ophthalmology, Eye and ENT Hospital of Fudan University, Shanghai, China; National Health Commission Key Laboratory of Myopia and Related Eye Diseases, Fudan University, Shanghai, China; Shanghai Research Center of Ophthalmology and Optometry, Shanghai, China; Key Laboratory of Myopia and Related Eye Diseases, Chinese Academy of Medical Sciences, Shanghai, China.
Asia Pac J Ophthalmol (Phila). 2025 Jul-Aug;14(4):100222. doi: 10.1016/j.apjo.2025.100222. Epub 2025 Jun 28.
Phakic Intraocular Lens (pIOL) has been studied for correction of high myopia and myopic astigmatism long before the advent of laser refractive surgery. It offers excellent visual and refractive outcomes, but the inherited risk of intraocular surgery cannot be overlooked. The posterior chamber pIOL (PC-pIOL), designed to be placed in the ciliary sulcus, may offer additional advantages compared to its anterior chamber counterparts. Given the complexity of sulcus anatomy and individual variations, controversies exist regarding perioperative management, implant selection, and operative techniques, necessitating standardisation. Given the emergence of novel approaches and long-term clinical data, a panel comprising 19 international experts from 9 countries/territories was formed by the Academy of Asia-Pacific Professors of Ophthalmology (AAPPO) and the Asia-Pacific Myopia Society (APMS). The panel critically reviewed the subject and synthesised 58 consensus statements that aim to provide evidence-based, real-world practice recommendations for optimal outcomes in PC-pIOL surgery.
在激光屈光手术出现之前很久，有晶体眼人工晶状体（pIOL）就已被用于研究矫正高度近视和近视散光。它能带来出色的视觉和屈光效果，但眼内手术固有的风险不容忽视。设计用于放置在睫状沟的后房型pIOL（PC-pIOL）相比前房型pIOL可能具有更多优势。鉴于睫状沟解剖结构的复杂性和个体差异，在围手术期管理、植入物选择和手术技术方面存在争议，因此需要标准化。鉴于新方法的出现和长期临床数据，亚太眼科学教授学会（AAPPO）和亚太近视协会（APMS）组建了一个由来自9个国家/地区的19名国际专家组成的小组。该小组对该主题进行了严格审查，并综合了58条共识声明，旨在为PC-pIOL手术的最佳效果提供基于证据的实际操作建议。
